Zymeworks Announces Participation in Upcoming Investor Conferences
(NASDAQ:ZYME), VANCOUVER, British Columbia, Oct. 28, 2025 (GLOBE NEWSWIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease, today announced that management will participate in the following upcoming investor conferences: Stifel Healthcare […]